It was previously reported that the acquired resistance to rhARG1 in melanoma cells in vivo was due to the altered expression of the two transcription factors c-Myc and HIF-1α, which are positive and negative regulators, respectively, of ASS1 gene expression [23]. The gene discussed is MYC; the disease is melanoma.